544709

- Trading window for designated persons and their immediate relatives closed from July 01, 2026. - Closure is for the upcoming unaudited financial results for the quarter ending June 30, 2026. - The Board meeting date for approving the financial results will be intimated separately.

- Corrigendum filed to correct inadvertent regrouping and typographical errors in the comparative consolidated financial figures for the year ended March 31, 2025. This includes minor adjustments to assets, liabilities, and tax expenses. - These corrections do not impact the current year's (March 31, 2026) financial results, PAT, Net Worth, or the auditor's report. - Standalone financial results for all periods were correctly reported.

- Board approved setting up "Gaudium Women Hospital, Lucknow" through a 30-year land lease arrangement. - Estimated project cost is up to ₹15 Crores towards development and operationalization. - The company will pay 10% of net revenue to the landowner and place a security deposit of ₹3 Crores.

- Analyst/Institutional Investor Meet scheduled by Gaudium IVF and Women Health Limited. - Date of Meet: Friday, June 12, 2026 - Time: 11:00 AM to 12:00 PM - With: InsightX Conference, organized by Choice Broking - Note: Discussions will be based on publicly available information; no UPSI will be shared.

Gaudium IVF and Women Health Limited announced the availability of the audio recording of its Earnings Call on the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. The recording, held on May 29, 2026, is accessible on the company's website.

Consolidated Revenue ₹30.35 Cr vs ₹26.92 Cr (▲12.74% YoY), EBITDA ₹12.17 Cr vs ₹8.72 Cr (▲39.56% YoY), PAT ₹8.36 Cr vs ₹6.45 Cr (▲29.46% YoY). EBITDA Margin 40.10% vs 32.39% (▲771bps).

Consolidated Revenue ₹30.35Cr vs ₹26.92Cr (▲12.73% YoY), EBITDA ₹12.17Cr vs ₹8.72Cr (▲39.56% YoY), PAT ₹8.36Cr vs ₹6.46Cr (▲29.46% YoY). EBITDA Margin 40.11% vs 32.39% (▲772bps).

Gaudium IVF and Women Health Limited reported strong financial performance for the quarter ended March 31, 2026. Consolidated Revenue stood at ₹3,035.11 Lakhs compared to ₹2,692.43 Lakhs (▲12.73% YoY). EBITDA significantly increased to ₹1,234.94 Lakhs from ₹895.61 Lakhs (▲37.88% YoY). Net Profit (PAT) grew to ₹835.74 Lakhs from ₹645.56 Lakhs (▲29.46% YoY). EBITDA Margin expanded from 33.26% to 40.69% (▲743bps). The company also completed its IPO during the year.